Aetna Zepbound Prior Authorization: How to Get Approved in 2026 (and What to Do If You’re Denied)

If you have Aetna and someone told you that you need an Aetna Zepbound prior authorization — or you just opened a denial letter — here’s the short version. When your Aetna plan covers Zepbound, prior authorization is almost always required. (Prior authorization, or PA, just means your insurer wants proof before they’ll pay.) Your doctor sends that proof, not you. To approve Zepbound (tirzepatide) for weight loss, Aetna’s rules ask for a BMI of 30 or higher (or 27–29.9 with a qualifying condition), about six months in a structured diet-and-exercise program, and several other documents — all detailed below in one place.

But here’s the part that trips most people up, and it changed in 2025: if your plan shows Zepbound as “not covered” or “non-formulary,” that’s a different problem with a different fix — and a routine prior authorization won’t solve it. In July 2025, the pharmacy manager behind most Aetna plans dropped Zepbound for weight loss and made Wegovy the preferred drug instead. So for a lot of people right now, the drug simply isn’t on their list.

The good news, and the twist: that’s reversing. We read Aetna’s policy, the FDA label, and the latest pricing so you don’t have to, and we turned it into a plain plan you can hand your doctor. Let’s find out exactly where you stand.

The fastest way to read your situation

Find the line that sounds like your situation. Then read the section it points to.

Does Aetna require prior authorization for Zepbound?

When your Aetna pharmacy plan covers Zepbound, prior authorization is almost always required, and your prescriber submits it. But the bigger question is whether your plan covers Zepbound at all. A covered drug needs a PA; a non-covered or excluded drug needs a different path — a formulary exception, a medical exception, or an appeal.

Here’s the trap that wastes people the most time: they think “prior authorization” and “covered” mean the same thing. They don’t.

• Prior authorization means the drug is on your list, but Aetna wants proof you qualify before they pay.
• Coverage means your plan includes the drug in the first place.
• A covered drug can still get denied if your doctor leaves out a required document.
• A non-covered drug needs a medical exception (a request to cover something that’s normally not on your list).
• A true plan exclusion — where your employer carved out weight-loss drugs on purpose — usually can’t be fixed with a routine PA at all.

Does Aetna cover Zepbound right now? (And why it changed)

Whether Aetna covers Zepbound depends on your specific plan. Effective July 1, 2025, CVS Caremark — the pharmacy manager behind many Aetna plans — removed Zepbound from its Standard Control, Advanced Control, and Value drug lists for weight loss and made Wegovy the preferred option. On May 28, 2026, CVS Caremark announced it will add Zepbound back to those lists as a preferred option on October 1, 2026. Self-funded employer plans set their own rules, so coverage still varies.

Aetna is part of CVS Health, and many Aetna pharmacy benefits run through CVS Caremark — the company that decides which drugs are “covered” and at what price. When Caremark changes its standard drug list, Aetna members on that list are affected. But plan sponsors (your employer) can customize coverage, so your plan document still controls.

Here’s the timeline that matters:

So what does this mean for you, in plain terms?

• If you have a standard Aetna commercial plan, Zepbound for weight loss has probably been off your list since July 2025. That’s why you may be getting denials that feel random. It can return on October 1, 2026 — but only if your plan sponsor adopts the change, so don’t assume; confirm it in your member portal.
• Until then, your real options are the sleep apnea path (if it applies), a medical exception, switching to covered Wegovy for now, or paying out of pocket (often cheaper than you think — see below).
• The big exception: self-funded employer plans pick their own drug list. Many never dropped Zepbound. This is exactly why you can’t guess — you have to check your own plan.

What are the Aetna Zepbound prior authorization requirements?

When Aetna covers Zepbound, its clinical policy splits the rules by reason. For weight loss, Aetna asks for a BMI of 30 or higher (or 27 or higher with a weight-related condition) and documentation of about six months in a structured diet-and-exercise program. For sleep apnea, it asks for a confirmed moderate-to-severe diagnosis — an apnea-hypopnea index of 15 or higher — plus a BMI of 30 or higher. Initial approval runs 8 months for weight loss and 6 months for sleep apnea; renewals run up to 12 months.

If you’re treating weight (the most common path)

Aetna generally wants all of these, with documents to back each one:

• BMI of 30 or higher (obesity), or BMI of 27 or higher with at least one weight-related condition — for example high blood pressure, high cholesterol, type 2 diabetes, or sleep apnea.
• About six months of a structured weight-management program — diet, exercise, and behavior changes — before starting the drug. This is the single most-missed requirement, and it’s the one Aetna’s own bulletin calls for.
• Used with a reduced-calorie diet and more activity (this is the FDA-approved way to use it).
• No reasons you shouldn’t take it — your doctor confirms you don’t have certain conditions (see safety section below).

If you’re treating sleep apnea

Zepbound is also FDA-approved for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity — a separate, official use. The FDA cleared this as the first drug treatment option for OSA in December 2024. For this path, Aetna’s rules generally ask for:

• A BMI of 30 or higher.
• A sleep study showing an apnea-hypopnea index (AHI) of 15 or more. (AHI counts how many times per hour your breathing pauses; 15 or higher is “moderate to severe.”)

This path matters because it can work even on plans that exclude weight-loss drugs. More on that in the sleep apnea section below.

If you’re already on Zepbound and need to renew

Renewals have their own bar. Aetna generally wants proof the drug is working: about three months at a stable dose, plus at least 5% weight loss from where you started (or holding a 5% loss if you’d already lost it). Initial approval runs up to 8 months for weight loss and 6 months for sleep apnea; renewals run up to 12 months. If you plateau, document everything — a stall isn’t an automatic “no,” but you have to make the case.

Is Zepbound safe for you? Who it’s not for

How to check what your Aetna plan covers — before you file

The fastest way to know if Aetna covers your Zepbound is to log in to your Aetna member portal or call the number on your card and ask, in these exact words: “Is Zepbound on my plan’s formulary, and what is the prior-authorization requirement for my diagnosis?” Don’t stop at “it’s on the list” — the drug tier, the PA rules, your diagnosis, and any plan exclusion all change the real answer.

When you look at your plan’s drug list (the “formulary”), you’ll see short codes next to each drug. Here’s what they mean, so you can read your own coverage:

• PA — prior authorization required (proof needed before they pay).
• PB — preferred brand (covered, usually a mid-level copay; may still need a PA).
• NPB — non-preferred brand (covered, but a higher copay).
• NF — non-formulary (not on your covered list — this is the one that needs a medical exception).
• QL — quantity limit (a cap on how much per fill).
• ST — step therapy (you must try another drug first).
• Excluded / not covered — usually means a routine PA won’t help.

What your doctor should send with the prior authorization

A prescription alone is not enough. A strong Aetna Zepbound prior authorization includes your diagnosis codes, your BMI history, proof of a six-month weight program, any weight-related conditions, your sleep study if you’re using the sleep apnea path, your medication history, and the denial letter if you’re resubmitting. Hand your doctor’s office this exact list.

You don’t submit the PA — your doctor’s office does. But the request lives or dies on what’s attached, and you can make sure nothing’s missing.

If you’re treating weight, your doctor should attach:

• Your Aetna member ID and the diagnosis codes — obesity (E66.x) plus any weight-related condition (for example I10 for high blood pressure, E11.x for type 2 diabetes, E78.5 for high cholesterol, G47.33 for sleep apnea)
• Your current weight and BMI (plus an older one to show the trend)
• Notes showing about six months in a diet/exercise/behavior program — this is the one people forget
• Proof of any weight-related condition if your BMI is 27–29.9
• Any past weight-loss drugs you tried, and what happened (especially if Wegovy didn’t work or made you sick)
• Your current medication list
• The denial letter, if this is a resubmission

If you’re treating sleep apnea, your doctor should attach:

• Your sleep study report and your AHI number (must be 15 or higher)
• Your sleep apnea diagnosis
• Proof your BMI is 30 or higher
• A note that the prescription is for the sleep apnea diagnosis, not weight loss

Where is the Aetna Zepbound prior authorization form submitted?

Your doctor’s office submits the request — here’s how, so you can pass it along. For commercial Aetna plans, Aetna’s prescription-drug prior-authorization form lists these channels:

What to do if Aetna denied your Zepbound

Don’t appeal until you know the denial type. “Criteria not met,” “non-formulary,” “step therapy,” “excluded,” and “not medically necessary” are five different problems with five different fixes. The first move is always to request the written denial letter, which states the exact reason — then match it to the right response.

A denial feels final. It usually isn’t. But the fix depends entirely on why they said no. Here’s how to decode it.

Three different tools — use the right one:

• Resubmit when your first PA was simply incomplete. Don’t send the same packet twice; add what was missing.
• Medical exception when the drug isn’t covered or isn’t preferred. Your doctor explains why the covered alternative (like Wegovy) won’t work for you.
• Appeal when Aetna reviewed your request and denied it. For most commercial plans, you have up to 180 days to file an internal appeal. The plan must decide an internal appeal within 30 days for care you haven’t received yet, or 60 days for care you’ve already received. If that fails, you can request an external review by an independent reviewer — usually within about 4 months of the final denial. A standard external review is decided within 45 days, and an urgent one within about 72 hours. That reviewer’s decision is binding on Aetna.

The single most important first step: ask for the written denial letter if you don’t have it. You’re entitled to it, and it lists the exact reason — which is the thing your doctor’s appeal then answers, point by point. For a deep-dive on external reviews, see our GLP-1 external review appeals guide.

Can Aetna cover Zepbound for sleep apnea?

Sometimes — and it’s the path people miss most. Zepbound is FDA-approved for moderate-to-severe obstructive sleep apnea in adults with obesity, a separate use from weight loss. Because of that, some Aetna plans that exclude weight-loss drugs will still cover Zepbound for sleep apnea. You’ll need a real, documented diagnosis: a sleep study showing an AHI of 15 or higher, plus a BMI of 30 or higher.

This is the separate coverage path that opens when the weight-loss door is closed. When a plan’s exclusion is written for “weight-loss drugs,” a prescription for sleep apnea may fall outside that exclusion. And because the FDA approved Zepbound as the first drug treatment option for OSA, plans have less footing to call it “not necessary” when your diagnosis is solid.

Ask your doctor these questions:

• Do I have a documented sleep apnea diagnosis?
• What was my AHI? (It needs to be 15 or higher.)
• Does my current BMI meet the 30 threshold?
• Should we file the prior authorization under sleep apnea instead of weight loss?

What if you have Aetna Medicare or a Part D plan?

Aetna Medicare and Part D plans don’t follow the commercial rules. Medicare has historically excluded drugs used only for weight loss, so coverage runs through different paths: a new short-term Medicare program for weight management, the standard Part D process for other uses like sleep apnea, and a different appeal track with different deadlines.

The Medicare GLP-1 Bridge (new for 2026)

Starting July 1, 2026, a short-term federal program called the Medicare GLP-1 Bridge gives eligible Part D members access to certain weight-loss GLP-1s for a flat $50-a-month copay. It runs through December 31, 2027. Two things to know for Zepbound specifically: only the KwikPen version is included — the single-dose vial and single-dose pen are not — and the program is for weight management. (If you need Zepbound for sleep apnea, that goes through standard Part D, not the Bridge.) The $50 copay sits outside your regular Part D benefit, so it won’t count toward your deductible or your out-of-pocket cap. Eligibility is based on BMI plus health conditions, and your doctor submits a prior authorization to a central processor. (Source: CMS.)

Medicare appeals are different

If your denial letter mentions CVS Caremark, it’s a Part D drug appeal. You generally have 65 days from the notice to file, and Medicare drug-plan appeals are decided faster than commercial ones — typically within 7 days for a standard benefit appeal, or 72 hours for a fast (expedited) appeal. Use the Medicare path, not the commercial 180-day path.

What if Aetna changed your coverage while you were already taking Zepbound?

If you were already on Zepbound and Aetna stopped covering it, your best levers are continuation rights, a “current course of treatment” exception, and a strong medical-necessity argument. Gather your start date, dose history, weight response, and the Aetna letter before your doctor files a continuation request or medical exception.

This happened to a lot of people in 2025. If a drug was working and then got pulled, that’s not just frustrating — it can be a real medical argument in your favor. Many plans allow a “current course of treatment” exception, which asks the plan to keep covering something you’ve already started, especially if switching could harm your health. Your doctor makes that case.

What to document before you ask:

• Your start date and current dose
• Your weight before you started, and now
• How you’ve tolerated it (side effects, or lack of them)
• Why switching could be a bad idea medically, if your doctor agrees
• Any history with Wegovy, Saxenda, or other options
• The denial or formulary-change letter

Who can help you get Aetna to cover Zepbound?

Your own prescriber is the person who submits the clinical paperwork, and for most people that’s the simplest, cheapest route. If you don’t have a prescriber for this — or you want help with the insurance back-and-forth — a telehealth service with insurance support can run a free coverage check and submit the prior authorization for you. For brand-name, insurance-sensitive Zepbound, Ro is the option we’d point Aetna members to first, because it offers a free coverage checker and a concierge that handles PA paperwork.

Two groups have a real reason to use a telehealth service instead:

1. You don’t have a doctor treating you for this, and getting an appointment is a hassle.
2. You don’t want to fight the insurance paperwork alone, and you’d like someone to check your coverage and submit the PA for you.

Ro — best if you want a free coverage check and help with the paperwork

What it is: Ro is a telehealth program that prescribes FDA-approved, brand-name GLP-1s. Its pricing page lists the Zepbound KwikPen and the oral pill Foundayo (orforglipron) among its options, with the medication billed separately from the membership. Ro’s free GLP-1 Insurance Coverage Checker contacts your plan and sends back a personalized report on what’s covered and what it’ll cost. Ro says that when a prior authorization is required, its insurance concierge submits the paperwork for you, and the insurance path typically takes about 2 to 3 weeks.

Who it’s best for: people with commercial Aetna or FEHB coverage who want to know if Zepbound is covered before committing — and who would rather not chase the paperwork themselves.

What does Zepbound cost if Aetna won’t cover it?

If coverage truly isn’t an option, the cheapest legitimate way to get brand-name Zepbound is Eli Lilly’s own LillyDirect Self Pay Journey Program: about $299 a month for the 2.5 mg starter dose, $399 for 5 mg, and a flat $449 a month for every dose from 7.5 mg through 15 mg, as long as you refill within 45 days. That’s roughly half the brand’s regular price, and it requires a valid prescription.

Here’s the relief most people don’t know about: you have an FDA-approved-brand fallback that’s far cheaper than the sticker price — straight from the maker, no compounding, no gray market.

*The 2.5 mg dose is a starter dose, not a long-term maintenance dose — most people move up. To keep the $449 price on the 7.5–15 mg doses, you have to refill within 45 days of your last fill; miss the window and the regular price applies. A one-month supply is 28 days. A valid prescription is required. At a regular pharmacy with no program at all, Zepbound’s list price is roughly $1,000 or more per month. (Source: LillyDirect Self Pay Journey Program terms, effective February 23, 2026.)

• The Lilly Savings Card is for people with commercial insurance only — not Medicare or Medicaid. It can lower your cost when your plan does cover Zepbound. It’s set to expire 12/31/2026, so confirm current terms.
• On Medicare? You can use the LillyDirect self-pay prices (the savings card can’t be used with Medicare), and you may qualify for the Medicare GLP-1 Bridge — a flat $50 a month — starting July 1, 2026 (KwikPen only; see the Medicare section).
• Watch the calendar. If you have a standard Aetna commercial plan, self-pay may only be a bridge to October 1, 2026, when Zepbound can return to your list and an in-network PA could drop your cost to as little as $25 a month if you’re eligible.

How long does the whole process take?

Timing depends on which path you’re on. A routine commercial prior-authorization decision is due within about 15 days (72 hours if urgent). A telehealth insurance path runs about 2 to 3 weeks. A commercial internal appeal is decided within 30 days (before-care) or 60 days (after-care), and an external review within 45 days — or 72 hours if urgent. Medicare drug appeals are faster: about 7 days standard, 72 hours expedited.

A few things not to do

Don’t assume a denial means Zepbound is impossible — but don’t assume every denial is fixable with more paperwork, either. Read the denial reason, match it to the right fix, and never use inaccurate diagnosis coding or unsupported claims to force an approval.

• Don’t resubmit the same incomplete packet twice. Add what was missing, or you’ll get the same answer.
• Don’t ask for Mounjaro instead unless you actually have type 2 diabetes. Mounjaro also contains tirzepatide, but it’s FDA-approved to improve blood sugar in adults with type 2 diabetes, while Zepbound is the tirzepatide product approved for weight management and sleep apnea. Diagnosis coding must be truthful and match your real diagnosis.
• Don’t claim sleep apnea you can’t document. That path needs a real sleep study. Misrepresenting your diagnosis can have serious consequences.
• Don’t skip your plan document. Aetna’s own policy says its bulletins don’t guarantee coverage — your plan document is what decides. Read it.

What we verified (and what only you can confirm)

This guide is built from primary sources: Aetna’s clinical policy for Zepbound, the FDA label, CVS Caremark’s May 2026 announcement, Eli Lilly’s pricing terms, CMS Medicare rules, and federal appeal rules. It can’t see your specific plan, so a few things only you can confirm through your Aetna account.

Frequently asked questions

Does Aetna require prior authorization for Zepbound?

When your Aetna plan covers Zepbound, prior authorization is almost always required, and your doctor submits it with proof you meet the rules — your BMI, a weight-related condition if your BMI is 27–29.9, about six months in a weight-management program, and that you’re using it with diet and exercise. If your plan lists Zepbound as non-formulary or excluded, the fix is a medical exception or appeal, not a routine PA.

Why did Aetna stop covering my Zepbound?

Many Aetna plans use CVS Caremark, which removed Zepbound for weight loss from its Standard Control, Advanced Control, and Value lists on July 1, 2025 and made Wegovy preferred. On May 28, 2026, CVS Caremark announced Zepbound returns to those lists on October 1, 2026 for plan sponsors who choose to cover it.

What BMI do I need for Aetna to approve Zepbound?

Aetna’s policy generally requires a BMI of 30 or higher, or 27 or higher with at least one weight-related condition such as high blood pressure, high cholesterol, type 2 diabetes, or sleep apnea. Confirm the current rule for your plan.

How long does Aetna’s Zepbound prior authorization take?

For most commercial plans, federal rules require a decision within about 15 days, or 72 hours if your doctor flags it as urgent. In practice, many decisions come back faster.

Can Aetna cover Zepbound for sleep apnea if my plan excludes it for weight loss?

Sometimes. Zepbound is FDA-approved for moderate-to-severe obstructive sleep apnea in adults with obesity — a separate use — and some plans that exclude weight-loss coverage still cover it for sleep apnea. You need a confirmed diagnosis: a sleep study showing an AHI of 15 or higher and a BMI of 30 or higher. It is not guaranteed.

Aetna denied my Zepbound. What do I do?

First, request the written denial letter, which states the exact reason. If a document was missing, resubmit. If the drug isn’t on your list, file a medical exception. If Aetna reviewed and denied it, file an internal appeal — generally within 180 days for commercial plans — with a medical-necessity letter, then an external review if needed. Medicare drug appeals use a different track with a 65-day deadline.

What if I already take Zepbound and Aetna changed my coverage?

Gather your start date, dose history, weight response, and the Aetna letter, then ask your doctor about a continuation request or a medical exception. Switching a working medication can be a real medical argument in your favor.

Does Aetna Medicare cover Zepbound?

Medicare has historically excluded weight-loss-only drugs. Starting July 1, 2026, eligible Part D members can get the Zepbound KwikPen for weight management through the Medicare GLP-1 Bridge for a flat $50 a month, through December 31, 2027. Zepbound for sleep apnea goes through standard Part D instead.

What does Zepbound cost without Aetna coverage?

Through Eli Lilly’s LillyDirect Self Pay Journey Program, about $299 a month for 2.5 mg, $399 for 5 mg, and a flat $449 a month for 7.5 mg through 15 mg if you refill within 45 days — far below the brand’s regular and list prices. A valid prescription is required.

Is Wegovy the same as Zepbound?

No. Zepbound (tirzepatide) works on two hormone targets; Wegovy (semaglutide) works on one. They are not interchangeable, which matters if your plan makes you try Wegovy first and it doesn’t work for you.

Still not sure where you stand?

You’ve got the full picture now: whether your plan covers it, the exact rules, what your doctor needs to send, how to beat a denial, the sleep apnea path, the Medicare options, and what it costs if you have to pay yourself. That’s more than most people ever piece together — and more than enough to take your next step with confidence.

Related guides

• Does Aetna cover Zepbound? 2026 formulary guide
• Aetna Wegovy prior authorization: 2026 rules and checklist
• How to bypass step therapy with Aetna (GLP-1 guide)
• How to appeal a GLP-1 insurance denial: external review guide
• Medicare GLP-1 Bridge: $50/month Zepbound KwikPen, explained
• Does Prime Therapeutics cover Zepbound?

Sources

• CVS Health newsroom — GLP-1 coverage expansion / Zepbound returns October 1, 2026 (May 28, 2026); NBC News; Reuters; Boston Globe; Managed Healthcare Executive
• Pharmacy Times; Fierce Healthcare — July 2025 formulary change and the class-action lawsuit
• Aetna — clinical policy bulletin for Zepbound (Zepbound PA with Limit, 6947-C); prescription-drug prior-authorization form; 2026 participating-provider precertification list
• SingleCare — corroboration of the six-month program requirement, attributed to Aetna’s Pharmacy Clinical Policy Bulletins
• FDA — Zepbound (tirzepatide) prescribing information; FDA approval of the first medication for obstructive sleep apnea (December 2024); SURMOUNT-OSA (Malhotra et al., NEJM 2024)
• Eli Lilly / LillyDirect — Self Pay Journey Program terms (effective February 23, 2026); Lilly Savings Card terms
• HealthCare.gov — internal appeal and external review timelines; CMS — Medicare prescription-drug appeals
• CMS — Medicare GLP-1 Bridge (July 1, 2026–December 31, 2027; $50 copay; Zepbound KwikPen only)
• Ro — GLP-1 Insurance Coverage Checker; weight-loss program, pricing, and insurance pages

All coverage terms, prices, and deadlines verified June 3, 2026. Coverage rules and drug lists change; confirm your own plan details through your Aetna member portal or by calling the number on your member ID card.